Covestor Ltd - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,909,256$33,709,6010.72%
Boxer Capital, LLC 2,495,018$7,709,6060.41%
Sio Capital Management, LLC 350,000$1,081,5000.34%
Baker Brothers Advisors 10,123,824$31,282,6160.18%
EcoR1 Capital, LLC 1,157,452$3,576,5270.12%
GSA CAPITAL PARTNERS LLP 70,583$2180.02%
Pale Fire Capital SE 30,781$95,1130.01%
Woodline Partners LP 200,000$618,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 143,957$444,8270.00%
EXCHANGE TRADED CONCEPTS, LLC 32,907$101,6830.00%
View complete list of PRELUDE THERAPEUTICS INC shareholders